Next Article in Journal
A Computational Simulation Study of Benzamidine Derivatives Binding to Arginine-Specific Gingipain (HRgpA) from Periodontopathogen Porphyromonas gingivalis
Next Article in Special Issue
Carbonic Anhydrase I Is Recognized by an SOD1 Antibody upon Biotinylation of Human Spinal Cord Extracts
Previous Article in Journal / Special Issue
Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer
Open AccessReview

Biomarkers for Colorectal Cancer

The Tohkai Cytopathology Institute: Cancer Research and Prevention (TCI-CaRP), 5-1-2 Minami-Uzura, Gifu 500-8285, Japan
Department Oncologic Pathology, Kanazawa Medical University, 1-1 daigaku, Uchinada Ishikawa 920-0293, Japan
Department of Pharmacy, Kinjo Gakuin University of Pharmacy, Moriyama-Ku, Nagoya, Aichi 463-8521, Japan
Department of Physical Therapy, Kansai University of Health Sciences, Kumatori-Machi, Sennan-Gun, Osaka 590-0482, Japan
Cancer Prevention Basic Research Project, National Cancer Center Research Institute, Tokyo 104-0045, Japan
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2010, 11(9), 3209-3225;
Received: 18 August 2010 / Revised: 2 September 2010 / Accepted: 3 September 2010 / Published: 13 September 2010
(This article belongs to the Special Issue Biomarkers)
Colorectal cancer (CRC) is the third most common epithelial malignancy in the world. Since CRC develops slowly from removable precancerous lesions, detection of the lesion at an early stage by regular health examinations can reduce the incidence and mortality of this malignancy. Colonoscopy significantly improves the detection rate of CRC, but the examination is expensive and inconvenient. Therefore, we need novel biomarkers that are non-invasive to enable us to detect CRC quite early. A number of validation studies have been conducted to evaluate genetic, epigenetic or protein markers for identification in the stool and/or serum. Currently, the fecal occult blood test is the most widely used method of screening for CRC. However, advances in genomics and proteomics will lead to the discovery of novel non-invasive biomarkers. View Full-Text
Keywords: biomarkers; colorectal cancer; fecal biomarkers; genomic and epigenetic biomarkers; serum biomarkers; microRNA biomarkers; colorectal cancer; fecal biomarkers; genomic and epigenetic biomarkers; serum biomarkers; microRNA
MDPI and ACS Style

Tanaka, T.; Tanaka, M.; Tanaka, T.; Ishigamori, R. Biomarkers for Colorectal Cancer. Int. J. Mol. Sci. 2010, 11, 3209-3225.

AMA Style

Tanaka T, Tanaka M, Tanaka T, Ishigamori R. Biomarkers for Colorectal Cancer. International Journal of Molecular Sciences. 2010; 11(9):3209-3225.

Chicago/Turabian Style

Tanaka, Takuji; Tanaka, Mayu; Tanaka, Takahiro; Ishigamori, Rikako. 2010. "Biomarkers for Colorectal Cancer" Int. J. Mol. Sci. 11, no. 9: 3209-3225.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop